TERN Terns Pharmaceuticals, Inc.: institutional ownership and insider trading
11 funds reported holding $325M of Terns Pharmaceuticals, Inc. in their latest 13F filings; in Q2 2026 funds net sold $7.13B, with 0 new positions and 318 funds selling out; over the last 12 months insiders bought $0 and sold $7.06M on the open market.
Largest institutional holders of TERN
- VANGUARD GROUP INC — $223M
- JANUS HENDERSON GROUP PLC (JHG) — $77.5M
- Nuveen Asset Management, LLC — $14.6M
- CIBRA Capital Ltd — $7.98M
- MIZUHO SECURITIES USA LLC — $584K
- CIBC WORLD MARKETS CORP — $229K
- CWM, LLC — $220K
- CIBC Private Wealth Group LLC — $202K
- Orion Portfolio Solutions, LLC — $123K
- COMERICA BANK — $4.24K
Recent TERN insider trades
- Apr 1, 2026: Kuriakose Emil sold 942 shares ($49.7K)
- Mar 16, 2026: Burroughs Amy L. sold 14,583 shares ($681K)
- Feb 17, 2026: Burroughs Amy L. sold 14,583 shares ($572K)
- Jan 15, 2026: Burroughs Amy L. sold 68,749 shares ($2.55M)
5%+ owners
- BlackRock, Inc.: 6.8% (Schedule 13G/A, filed Feb 5, 2025)